Acarix gets Saudi MDMA certificate for its CADScor heart test system
Swedish medtech Acarix says its CADScor system obtained an MDMA certificate in Saudi Arabia; registration with the Ministry of Health comes next.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Swedish medical device company Acarix reported, according to Reuters, that its CADScor system has been granted an MDMA certificate by Saudi authorities, a regulatory green light in the country. TradingView, which carried the same announcement, adds that registration with the kingdom's Ministry of Health is the next step, with timing still being agreed with local partners.
CEO Aamir Mahmood called the step an important milestone in the firm's push into the Middle East and said the team is preparing for a commercial launch.
why it matters
For a small company listed on Nasdaq First North, this is an incremental step, since registration must be completed before any sales in the kingdom. The news carries limited weight for broader markets, but it shows progress in the firm's international rollout of its diagnostic tool.
tags
instruments
sources
- Acarix Receives Regulatory Approval In Saudi Arabia — Reuters, 19 October 2026 at 06:56 UTC
- Acarix receives Regulatory Approval in Saudi Arabia. — TradingView, 19 October 2026 at 06:53 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗